首页> 外国专利> Treating skin disease, e.g. psoriasis, with 3-substd. psoralen derivs. - in conjunction with UV radiation

Treating skin disease, e.g. psoriasis, with 3-substd. psoralen derivs. - in conjunction with UV radiation

机译:治疗皮肤病,例如银屑病,3。补骨脂素。 -结合紫外线辐射

摘要

Compsn. for treating skin diseases contains a psoralen deriv. of formula (I) (where R1 is COOR3 or CN; R2 is H or CH3; and R3 is H, CH3 or C2H5. Cpds. (I) are new where R2=H; R1 = COOCH3 or CN. Used esp. for oral or topical treatment of psoriasis punctata, herpes simplex, mycosis fungoides, microbial eczema, acne, etc. in conjunction with UV irradiation. The usual oral dose is 1-2 mg/kg while topical compsns. contain 0.5-4 esp. 1-2% (I). Unlike 8-methoxypsoralen (I) do not induce erythema, tanning, tumours or other skin injury and do not reduce the number of lymphocytes in the blood. 3-Carbethoxy-psoralen caused no deaths and no loss of wt. when given intraperitoneally to mice at 36x 0.4 mg over 7 weeks.
机译:Compsn。用于治疗皮肤疾病的含有补骨脂素衍生物。式(I)的化合物(其中R1是COOR3或CN; R2是H或CH3;并且R3是H,CH3或C2H5。)(I)是新的,其中R2 = H; R1 = COOCH3或CN。银屑病,单纯疱疹,真菌病,真菌性湿疹,痤疮等经紫外线照射的口服或局部治疗,通常口服剂量为1-2 mg / kg,局部用药为0.5-4 esp。1- 2%(I)。与8-甲氧基补骨脂素(I)不同,它不会引起红斑,晒黑,肿瘤或其他皮肤损伤,并且不会减少血液中的淋巴细胞数量; 3-甲氧甲氧基补骨脂素不会导致死亡,也不会导致wt损失当在7周内以36x 0.4 mg腹膜内给予小鼠时。

著录项

  • 公开/公告号IT1165158B

    专利类型

  • 公开/公告日1987-04-22

    原文格式PDF

  • 申请/专利号IT19790067404

  • 发明设计人

    申请日1979-02-23

  • 分类号A61K;

  • 国家 IT

  • 入库时间 2022-08-22 07:18:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号